{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23635914",
  "DateCompleted": {
    "Year": "2014",
    "Month": "06",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2014",
    "Month": "07",
    "Day": "31"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1097/EJA.0b013e328361d395"
    ],
    "Journal": {
      "ISSN": "1365-2346",
      "JournalIssue": {
        "Volume": "30",
        "Issue": "12",
        "PubDate": {
          "Year": "2013",
          "Month": "Dec"
        }
      },
      "Title": "European journal of anaesthesiology",
      "ISOAbbreviation": "Eur J Anaesthesiol"
    },
    "ArticleTitle": "Lorazepam does not improve the quality of recovery in day-case surgery patients: a randomised placebo-controlled clinical trial.",
    "Pagination": {
      "StartPage": "743",
      "EndPage": "751",
      "MedlinePgn": "743-51"
    },
    "Abstract": {
      "AbstractText": [
        "In day-case surgery, the effects of the anxiolytic lorazepam as premedication on the quality of postoperative recovery are unknown.",
        "To evaluate whether lorazepam as a premedication beneficially affects quality of recovery (primary outcome) and psychological manifestations (secondary outcome) after day-case surgery.",
        "A randomised, double-blind, placebo-controlled clinical trial.",
        "Single tertiary centre.",
        "day-case surgery; age at least 18 years.",
        "insufficient knowledge of the Dutch language; intellectual disability; ophthalmology surgery; extracorporeal shock wave lithotripsy; endoscopy; botulinum toxin A treatment; abortion; chronic pain treatment; preceding use of psychopharmaceuticals; contraindication to lorazepam.",
        "Lorazepam (1 to 1.5\u200amg) intravenously vs. NaCl 0.9% as a premedication prior to surgery.",
        "Quality of Recovery-40 (QoR-40) score.",
        "State-Trait Anxiety Inventory (STAI-State/Trait); State-Trait Anger Scale (STAS-State/Trait); Multidimensional Fatigue Inventory (MFI); Hospital Anxiety and Depression Scale (HADS). Timing of evaluation: T0: preoperatively (all scales); T1: before discharge (STAI-State/Trait); T2: first postoperative working day (QoR-40); T3: 7th day after surgery (all scales). Robust regression analysis was applied. Statistical analyses were adjusted for the corresponding baseline value and sex.",
        "Four hundred patients were randomised; 398 patients were analysed. Postoperative mean QoR-40 scores were similar in both groups at T2 (174.5 vs. 176.4, P\u200a=\u200a0.34) and T3 (172.8 vs.176.3, P\u200a=\u200a0.38). Postoperative mean STAI-State/Trait scores decreased less in the group with lorazepam at T1 (32.3 vs. 29.3, P\u200a<\u200a0.0001; 32.7 vs. 30.8, P\u200a=\u200a0.0002). STAI-Trait and HADS-Anxiety decreased less in the group with lorazepam at T3 (31.1 vs. 30.0; P\u200a=\u200a0.03, 3.3 vs. 2.5, P\u200a=\u200a0.003). STAS-State increased in the group with lorazepam at T3 (10.8 vs. 10.3, P\u200a=\u200a0.04).",
        "In day-case surgery, lorazepam as a premedication did not improve quality of recovery. Furthermore, this premedication may delay the decrease in postoperative anxiety and aggression.",
        "ClinicalTrials.gov identifier: NCT01441843."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "From the Department of Anaesthesiology, Erasmus University Medical Centre, Rotterdam, The Netherlands."
          }
        ],
        "LastName": "Mijderwijk",
        "ForeName": "Herjan",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "van Beek",
        "ForeName": "Stefan",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Klimek",
        "ForeName": "Markus",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Duivenvoorden",
        "ForeName": "Hugo J",
        "Initials": "HJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gr\u00fcne",
        "ForeName": "Frank",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Stolker",
        "ForeName": "Robert Jan",
        "Initials": "RJ"
      }
    ],
    "DataBankList": [
      {
        "DataBankName": "ClinicalTrials.gov",
        "AccessionNumberList": [
          "NCT01441843"
        ]
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Randomized Controlled Trial",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Eur J Anaesthesiol",
    "NlmUniqueID": "8411711",
    "ISSNLinking": "0265-0215"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Anxiety Agents"
    },
    {
      "RegistryNumber": "O26FZP769L",
      "NameOfSubstance": "Lorazepam"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Eur J Anaesthesiol. 2013 Dec;30(12):731-3",
      "PMID": "24169624"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Aggression"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Ambulatory Surgical Procedures"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Anxiety Agents"
    },
    {
      "QualifierName": [
        "epidemiology",
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Double-Blind Method"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Lorazepam"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Postoperative Period"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Premedication"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychiatric Status Rating Scales"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Regression Analysis"
    }
  ]
}